Norges Bank’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-174,820
| Closed | -$5.08M | – | 108 |
|
|
2025
Q4 | $5.08M | Buy |
+174,820
| New | +$4.48M | ﹤0.01% | 1385 |
|
|
2025
Q3 | – | Sell |
-174,820
| Closed | -$2.45M | – | 124 |
|
|
2025
Q2 | $2.45M | Sell |
174,820
-504,500
| -74% | -$7.07M | ﹤0.01% | 1401 |
|
|
2025
Q1 | $10.6M | Buy |
679,320
+146,527
| +28% | +$2.06M | ﹤0.01% | 1271 |
|
|
2024
Q4 | $7.42M | Buy |
532,793
+357,973
| +205% | +$3.92M | ﹤0.01% | 1409 |
|
|
2024
Q3 | $1.63M | Hold |
174,820
| – | – | ﹤0.01% | 1681 |
|
|
2024
Q2 | $1.63M | Hold |
174,820
| – | – | ﹤0.01% | 1757 |
|
|
2024
Q1 | $1.73M | Buy |
174,820
+93,808
| +116% | +$700K | ﹤0.01% | 1748 |
|
|
2023
Q4 | $262K | Hold |
81,012
| – | – | ﹤0.01% | 1920 |
|
|
2023
Q3 | $430K | Hold |
81,012
| – | – | ﹤0.01% | 1927 |
|
|
2023
Q2 | $772K | Hold |
81,012
| – | – | ﹤0.01% | 1946 |
|
|
2023
Q1 | $891K | Hold |
81,012
| – | – | ﹤0.01% | 2012 |
|
|
2022
Q4 | $1.2M | Hold |
81,012
| – | – | ﹤0.01% | 2034 |
|
|
2022
Q3 | $1.55M | Buy |
81,012
+19,896
| +33% | +$451K | ﹤0.01% | 1946 |
|
|
2022
Q2 | $1.3M | Hold |
61,116
| – | – | ﹤0.01% | 1940 |
|
|
2022
Q1 | $1.18M | Sell |
61,116
-204,277
| -77% | -$3.46M | ﹤0.01% | 2032 |
|
|
2021
Q4 | $5.5M | Buy |
265,393
+204,277
| +334% | +$4.07M | ﹤0.01% | 1897 |
|
|
2021
Q3 | $1.46M | Hold |
61,116
| – | – | ﹤0.01% | 2102 |
|
|
2021
Q2 | $1.67M | Hold |
61,116
| – | – | ﹤0.01% | 2043 |
|
|
2021
Q1 | $1.77M | Buy |
61,116
+40,000
| +189% | +$1.25M | ﹤0.01% | 2004 |
|
|
2020
Q4 | $594K | Hold |
21,116
| – | – | ﹤0.01% | 2069 |
|
|
2020
Q3 | $619K | Buy |
+21,116
| New | +$564K | ﹤0.01% | 2068 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
